Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR‐2 and DNA gyrase inhibition, and in silico studies
作者:Soha H. Emam、Rasha A. Hassan、Eman O. Osman、Mohammed I. A. Hamed、Amr M. Abdou、Mai M. Kandil、Eman Maher Elbaz、Demiana S. Mikhail
DOI:10.1002/ddr.22037
日期:——
A series of coumarin derivatives were designed, synthesized, and evaluated for their antiproliferative activity. Compound 3e exhibited significant antiproliferative activity and was further evaluated at five doses at the National Cancer Institute. It effectively inhibited vascular endothelial growth factor receptor-2 (VEGFR-2) with an IC50 value of 0.082 ± 0.004 µM compared with sorafenib. While compound
设计、合成了一系列香豆素衍生物,并评估了它们的抗增殖活性。化合物3e表现出显着的抗增殖活性,并在国家癌症研究所进一步评估了五个剂量。与索拉非尼相比,它能有效抑制血管内皮生长因子受体 2 (VEGFR-2),IC 50值为 0.082 ± 0.004 µM。虽然化合物3e显着下调了总 VEGFR-2 及其磷酸化,但它显着降低了 HUVEC 的迁移潜力,导致伤口愈合显着中断。此外,化合物3e导致白血病细胞系 HL-60(TB) 总凋亡水平增加 22.51 倍,caspase-3 水平增加 6.91 倍。化合物3e还引起细胞周期停滞,主要是在 G1/S 期。针对革兰氏阳性和革兰氏阴性细菌菌株评估抗菌活性。化合物3b是活性最强的衍生物,对肺炎克雷伯菌具有相同的最低抑菌浓度和最低杀菌浓度值128 μg/mL ,在哺乳动物血浆中稳定性高。此外,与 IC 50 的新生霉素相比,化合物3b和3f抑制革兰氏阴性